bioRxiv (Cold Spring Harbor Laboratory)
August 14, 2020
N. Jones, Zarmeen Zahid, Sean M. Grady et al.
9 citations
preprint
Abstract Despite observed correlations between acute glucocorticoid release, self-reported anxiety, and long-term treatment outcomes for human studies using psilocybin-assisted psychotherapy approaches, the mechanistic relationship between psychedelic-dependent stress and subsequent behavioral responses remains unclear. Using rodents, direct manipulation of stress-associated hormone responses...
bioRxiv (Cold Spring Harbor Laboratory)
July 30, 2020
Sergio Hernández, Roberto Dorta‐Guerra, José Suero et al.
2 citations
preprint
Abstract Objectives Our previous study showed that long-term practitioners of Sahaja Yoga Meditation (SYM) had around 7% larger grey matter volume (GMV) in the whole brain compared with healthy controls; however, when testing individual regions, only 5 small brain areas were statistically different between groups. Under the hypothesis that those results were statistically conservative, with the...
bioRxiv (Cold Spring Harbor Laboratory)
July 24, 2020
Timo Torsten Schmidt, Simon Reiche, Caroline L. C. Hage et al.
preprint
ABSTRACT Kambô is the name for the secretion of the Giant Leaf Frog (Phyllomedusa bicolor) containing a plethora of bioactive peptides. Originally, it is ritually used by different ethnicities from the Amazon basin as a remedy against bad luck in hunting. In the last twenty years, Kambô has spread to Western urban centers, often associated with the use of ayahuasca. Anecdotal reports claim...
bioRxiv (Cold Spring Harbor Laboratory)
July 14, 2020
Shreyas Bhat, Daryl A. Guthrie, Ameya Kasture et al.
3 citations
preprint
Abstract Missense mutations that give rise to protein misfolding are rare, but collectively, defective protein folding diseases are consequential. Folding deficiencies are amenable to pharmacological correction (pharmacochaperoning), but the underlying mechanisms remain enigmatic. Ibogaine and its active metabolite noribogaine correct folding defects in the dopamine transporter (DAT), but they...
bioRxiv (Cold Spring Harbor Laboratory)
June 29, 2020
Joaquín González, Matías Cavelli, Santiago Castro-Zaballa et al.
5 citations
preprint
Abstract Ibogaine is a psychedelic alkaloid that has attracted scientific interest because of its important antiaddictive properties evidenced in observational studies in humans, and in models for substance-use-disorders in rodents. Its subjective effect has been described as intense vivid dream-like experiences occurring while awake; hence, ibogaine is often referred to as an oneirogenic...
bioRxiv (Cold Spring Harbor Laboratory)
June 20, 2020
Jacob van Doorn, Mengqi Xing, B. Rael Cahn et al.
1 citation
preprint
Abstract Alterations in brain connectivity has been shown for many disease states and groups of people from different levels of cognitive training. To study dynamic functional connectivity, we propose a method for a personalized connectomic state space called Thought Chart. Experienced meditators are an interesting group of healthy subjects for brain connectivity analyses due to their...
bioRxiv (Cold Spring Harbor Laboratory)
June 11, 2020
Tim Hirschfeld, Timo Torsten Schmidt
8 citations
preprint
Abstract Psilocybin is the active component of magic mushrooms and is well known for its psychoactive properties. Different questionnaires have been developed to systematically quantify altered states of consciousness induced by psychoactive drugs. The aim of this study was to obtain the dose-response relationships of the subjective experiences induced by psilocybin in healthy study...
bioRxiv (Cold Spring Harbor Laboratory)
April 1, 2020
Matthew L. Dixon, Manesh Girn, Kalina Christoff
14 citations
preprint
Abstract Individuals use various strategies to cope with challenging emotions such as anxiety. Mindful acceptance involves broadening attentional scope and fully experiencing present moment sensory feelings (whether pleasant or unpleasant) without judgment or elaboration. In contrast, narrative-evaluation involves focusing on a narrow band of sensory experience and generating an elaborate...
bioRxiv (Cold Spring Harbor Laboratory)
January 23, 2020
Ca Hales, Jm Bartlett, Roberto Arban et al.
preprint
Abstract Major Depressive Disorder is a significant and costly cause of global disability. Until the discovery of the rapid acting antidepressant (RAAD) effects of ketamine, treatments were limited to drugs that have delayed clinical benefits. The mechanism of action of ketamine is currently unclear but one hypothesis is that it may involve neuropsychological effects mediated through modulation...
bioRxiv (Cold Spring Harbor Laboratory)
December 19, 2019
J.M. Barnby, Vaughan Bell, Quinton Deeley et al.
4 citations
preprint
Abstract Altered dopamine transmission is thought to influence the formation of persecutory delusions. However, despite extensive evidence from clinical studies there is little experimental evidence on how modulating the dopamine system changes social attributions related to paranoia, and the salience of beliefs more generally. 27 healthy male participants received 150mg L-DOPA, 3mg...
bioRxiv (Cold Spring Harbor Laboratory)
December 6, 2019
Felipe Augusto Cini da Silva, Isis M. Ornelas, Encarni Marcos et al.
9 citations
preprint
Abstract Psychedelic agonists of serotonin receptors induce neural plasticity and synaptogenesis, but their potential to enhance learning remains uncharted. Here we show that a single dose of d-LSD, a potent serotonergic agonist, increased novel object preference in young and adult rats several days after treatment. d-LSD alone did not increase preference in old animals, but could rescue it to...
bioRxiv (Cold Spring Harbor Laboratory)
November 9, 2019
Hanna M. Ollila, Nasa Sinnott-Armstrong, Katri Kantojärvi et al.
5 citations
preprint
ABSTRACT Nightmares are vivid, extended and extremely dysphoric dreams that awaken the dreamer. Twin studies indicate that nightmare frequency has a heritability between 36 and 51% providing evidence for genetic factors underlying predisposition to nightmares. Furthermore, while cross-sectional epidemiological findings suggest that heavy alcohol usage, traumatic experiences and psychiatric...
bioRxiv (Cold Spring Harbor Laboratory)
September 23, 2019
Kirsten C. S. Adam, Manoj K. Doss, Elisa Pabon et al.
2 citations
preprint
Abstract With the increasing prevalence of legal cannabis use and availability, there is an urgent need to identify cognitive impairments related to its use. It is widely believed that cannabis, or its main psychoactive component Δ 9 -tetrahydrocannabinol (THC), impairs working memory, i.e., the ability to temporarily hold information in mind. However, our review of the literature yielded...
bioRxiv (Cold Spring Harbor Laboratory)
September 8, 2019
Laura Alethia de la Fuente, Federico Zamberlán, Andrés Sánchez Ferrán et al.
1 citation
preprint
Abstract Background Commercially available cannabis strains have multiplied in recent years as a consequence of regional changes in legislation for medicinal and recreational use. Lack of a standardized system to label plants and seeds hinders the consistent identification of particular strains with their elicited psychoactive effects. The objective of this work was to leverage information...
bioRxiv (Cold Spring Harbor Laboratory)
July 19, 2019
Natasha L. Mason, Eef L. Theunissen, Nadia R. P. W. Hutten et al.
4 citations
preprint
Abstract Cannabis is the most commonly used illicit drug in the world. However due to a changing legal landscape, and rising interest in therapeutic utility, there is an increasing trend in (long-term) use and possibly, cannabis impairment. Importantly, a growing body of evidence suggests regular cannabis users develop tolerance to the impairing, as well as the rewarding, effects of the drug....
bioRxiv (Cold Spring Harbor Laboratory)
June 17, 2019
Tetiana Kardash, Dmitry Rodin, Michael Kirby et al.
preprint
ABSTRACT The effects of cannabis reported by users range from experiences of euphoria and anxiolytic effects to paranoia, anxiety, and increased risk of depression. Attempts to reconcile the apparent contradictions in user response have not been conclusive. Here, we utilized selectively-bred stress-resilient socially dominant (Dom) and stress-sensitive socially submissive (Sub) mice to...
bioRxiv (Cold Spring Harbor Laboratory)
April 14, 2019
J.R. Payne, Oliver Baell, Harry Geddes et al.
6 citations
preprint
Abstract Objectives Long-term meditation practice affects the brain’s ability to sustain attention. However, how this occurs is not well understood. Electroencephalography (EEG) studies have found that during dichotic oddball listening tasks, experienced meditators displayed altered attention-related neural markers including theta phase synchronisation (TPS) and event-related potentials (ERP;...
bioRxiv (Cold Spring Harbor Laboratory)
March 9, 2019
Andria Pelentritou, Levin Kuhlmann, John Cormack et al.
1 citation
preprint
B. Abstract Background. Despite their intriguing nature, investigations of the neurophysiology of N-methyl-D-aspartate (NMDA)-antagonists Xenon (Xe) and nitrous oxide (N 2 O) are limited and have revealed inconsistent frequency-dependent alterations, in spectral power and functional connectivity. Discrepancies are likely due to using low resolution electroencephalography restricted to sensor...
bioRxiv (Cold Spring Harbor Laboratory)
January 11, 2019
Tf. Varley, Robin Carhart-Harris, Leor Roseman et al.
8 citations
preprint
Abstract Psychedelic drugs, such as psilocybin and LSD, represent unique tools for researchers in-vestigating the neural origins of consciousness. Currently, the most compelling theories of how psychedelics exert their effects is by increasing the complexity of brain activity and moving the system towards a critical point between order and disorder, creating more dynamic and complex patterns of...
bioRxiv (Cold Spring Harbor Laboratory)
January 4, 2019
David J. Schwartzman, Michael Schartner, Benjamin B. Ador et al.
31 citations
preprint
Abstract What are the global neuronal signatures of altered states of consciousness (ASC)? Recently, increases in neural signal diversity, compared to those found in wakeful rest, have been reported during psychedelic states. Neural signal diversity has previously been identified as a robust signature of the state of consciousness, showing lower scores during sleep or anaesthesia compared to...
bioRxiv (Cold Spring Harbor Laboratory)
July 25, 2018
Ali R. Awan, Jaclyn M. Winter, Daniel J. Turner et al.
26 citations
preprint
Abstract Psilocybin is a psychoactive compound with clinical applications produced by dozens of mushroom species 1 . There has been a longstanding interest in psilocybin research with regard to treatment for addiction 2 , depression 3 , and end-of-life suffering 4 . However, until recently very little was known about psilocybin biosynthesis and its ecological role. Here we confirm and refine...
bioRxiv (Cold Spring Harbor Laboratory)
July 25, 2018
Louis-David Lord, Paul Expert, Selen Atasoy et al.
10 citations
preprint
Abstract Brain activity can be understood as the exploration of a dynamical landscape of activity configurations over both space and time. This dynamical landscape may be defined in terms of spontaneous transitions within a repertoire of discrete metastable states of functional connectivity (FC), which underlie different mental processes. However, it remains unclear how the brain’s dynamical...
bioRxiv (Cold Spring Harbor Laboratory)
July 24, 2018
Greg R. Boyce, Emile Gluck‐thaler, Jason C. Slot et al.
1 citation
preprint
Abstract Entomopathogenic fungi routinely kill their hosts before releasing infectious spores, but select species keep insects alive while sporulating, which enhances dispersal. Transcriptomics and metabolomics studies of entomopathogens with post-mortem dissemination from their parasitized hosts have unraveled infection processes and host responses, yet mechanisms underlying active spore...
bioRxiv (Cold Spring Harbor Laboratory)
January 31, 2018
Ana Cecília de Menezes Galvão, Raíssa Nóbrega de Almeida, Erick Allan Dos Santos Silva et al.
5 citations
preprint
ABSTRACT Major depression is a highly prevalent mood disorder, affecting about 350 million people, and around 30% of the patients are resistant to currently available antidepressant medications. Recent evidence from a randomized placebo-controlled trial supports the rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression. The aim of this study was to explore...
bioRxiv (Cold Spring Harbor Laboratory)
January 25, 2018
Flávia Santos Da Silva, Erick Allan Dos Santos Silva, Geovan Menezes de Sousa et al.
4 citations
preprint
ABSTRACT The incidence of major depression in adolescents, aged between 15 to 18 years, reaches approximately 14%. Usually, this disorder presents a recurrent way, without remission of symptoms even after several pharmacological treatments, persisting through adult life. Due to the relatively low efficacy of commercially available antidepressant, new pharmacological therapies are under...